We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.02B
AUM Growth
+$21.3M
Cap. Flow
-$7.99M
Cap. Flow %
-0.79%
Top 10 Hldgs %
30.61%
Holding
299
New
42
Increased
39
Reduced
128
Closed
11

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$4.93M
2
VTR icon
Ventas
VTR
+$4.73M
3
AR icon
Antero Resources
AR
+$3.4M
4
WELL icon
Welltower
WELL
+$2.7M
5
AGN
Allergan plc
AGN
+$2.69M

Top Sells

Rank Stock Value
1
TPH
Tri Pointe Homes
TPH
+$7.63M
2
GNTX icon
Gentex
GNTX
+$4.63M
3
ADNT icon
Adient
ADNT
+$3.64M
4
DNOW icon
DNOW Inc
DNOW
+$1.97M
5
AVY icon
Avery Dennison
AVY
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Industrials 14.37%
3 Financials 13.51%
4 Healthcare 13.29%
5 Consumer Discretionary 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNT
276
Senstar Technologies
SNT
$41.1M
$73K 0.01%
14,335
ARTW icon
277
Arts-Way Manufacturing Co
ARTW
$12.6M
$71K 0.01%
23,784
MIND icon
278
MIND Technology
MIND
$49.1M
$67K 0.01%
2,120
LEE icon
279
Lee Enterprises
LEE
$166M
$59K 0.01%
+2,500
New +$58.6K
ESV
280
DELISTED
Ensco Rowan plc
ESV
$59K 0.01%
+2,500
New +$55.4K
CERS icon
281
Cerus
CERS
$617M
$47K ﹤0.01%
14,000
ALTO icon
282
Alto Ingredients
ALTO
$349M
$46K ﹤0.01%
+10,000
New +$47.4K
EQS icon
283
Equus Total Return
EQS
$15.2M
$43K ﹤0.01%
17,735
JCP
284
DELISTED
J.C. Penney Company, Inc.
JCP
$41K ﹤0.01%
13,000
PDLI
285
DELISTED
PDL BioPharma, Inc.
PDLI
$32K ﹤0.01%
11,500
PED icon
286
PEDEVCO
PED
$164M
$31K ﹤0.01%
4,885
ARLZ
287
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$26K ﹤0.01%
17,987
ALIM
288
DELISTED
Alimera Sciences
ALIM
$13K ﹤0.01%
667
ADNT icon
289
Adient
ADNT
$1.61B
-43,321
Closed -$3.64M
DNOW icon
290
DNOW Inc
DNOW
$2.6B
-142,305
Closed -$1.97M
GNTX icon
291
Gentex
GNTX
$4.81B
-233,935
Closed -$4.63M
KN icon
292
Knowles
KN
$3.13B
-15,200
Closed -$232K
LYV icon
293
Live Nation Entertainment
LYV
$41.7B
-22,526
Closed -$981K
PHG icon
294
Philips
PHG
$26.1B
-6,641
Closed -$208K
SRI icon
295
Stoneridge
SRI
$211M
-12,500
Closed -$248K
SSD icon
296
Simpson Manufacturing
SSD
$8.02B
-16,330
Closed -$801K
SWKS icon
297
Skyworks Solutions
SWKS
$9.31B
-2,100
Closed -$214K
P
298
DELISTED
Pandora Media Inc
P
-17,500
Closed -$135K
OME
299
DELISTED
Omega Protein
OME
-47,000
Closed -$783K

Similar funds

Shufro Rose & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Shufro Rose & Co held 299 positions worth $1.02B, up 2.1% from $995M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q4 2017 filing shows 42 new, 39 increased, 128 reduced and 11 closed positions. Its largest new stake was Ventas: 74,780 shares worth $4.49M. The largest sale was Tri Pointe Homes, an estimated $7.63M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

  • Shufro Rose & Co's largest Q4 2017 buy was Ventas: 74,780 shares worth $4.49M.
  • Shufro Rose & Co added most to Synchrony in Q4 2017, an estimated $4.93M increase.
  • Shufro Rose & Co's biggest Q4 2017 reduction was Tri Pointe Homes, cutting an estimated $7.63M.
  • Shufro Rose & Co fully exited Gentex in Q4 2017, selling an estimated $4.63M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $1.02B portfolio in Q4 2017.
  • Shufro Rose & Co opened 42 new positions and closed 11 in Q4 2017.
  • Shufro Rose & Co's portfolio value rose 2.1% quarter-over-quarter to $1.02B.

Based on Shufro Rose & Co's 13F filing for Q4 2017, filed 6 Feb 2018.